Chinese guideline for clinical diagnosis and treatment of malignant pleural mesothelioma (2021 Edition) / 中华肿瘤杂志
Chinese Journal of Oncology
;
(12): 383-394, 2021.
Article
Dans Chinois
| WPRIM
| ID: wpr-877503
ABSTRACT
Malignant pleural mesothelioma (MPM) is a pleura-derived malignant tumor, with a gradually increasing incidence in recent years based on domestic and foreign epidemiologic data. Most patients with MPM are diagnosed at an advanced stage due to its insidiousness and aggressiveness. The therapeutic strategies of MPM mainly include surgery, chemotherapy and radiotherapy. Recently, the immunotherapy has altered the treatment pattern and further improved the survival of these patients. In order to timely present the domestic and foreign progress in the diagnosis and treatment of MPM, and to further improve the level of standardized diagnosis and treatment in MPM in China, this guideline was formulated on the basis of existing clinical research evidence combined with experts' opinions. The guideline covers the epidemiology, diagnosis, pathology, treatment and follow-up of MPM.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Tumeurs de la plèvre
/
Chine
/
Mésothéliome malin
/
Immunothérapie
/
Tumeurs du poumon
/
Mésothéliome
Type d'étude:
Etude diagnostique
/
Guide de pratique
Limites du sujet:
Humains
Pays comme sujet:
Asie
langue:
Chinois
Texte intégral:
Chinese Journal of Oncology
Année:
2021
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS